2',3'-dideoxyadenosine triphosphate has been researched along with 2'-deoxyadenosine triphosphate in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harada, S; Mitsuya, H; Wang, R; Zemlicka, J | 1 |
Amblard, F; Bassit, L; Bondada, L; Coats, SJ; Detorio, M; Grier, J; Hernandez-Santiago, BI; Koontz, D; Mellors, JW; Rapp, KL; Schinazi, RF; Sluis-Cremer, N | 1 |
Johnson, KA; Suo, Z | 1 |
Hori, K; Mori, K; Ogasawara, H; Saito, K; Takahashi, K; Takahashi, S | 1 |
Babusis, D; Durand-Gasselin, L; Flaherty, JF; Hawkins, T; Ray, AS; Reddy, YS; Veikley, W | 1 |
Baev, D; Cahn, P; Calarota, SA; De Forni, D; Katabira, E; Lori, F; Maserati, R; Rakhmanova, A; Stevens, MR; Testori, M | 1 |
2 trial(s) available for 2',3'-dideoxyadenosine triphosphate and 2'-deoxyadenosine triphosphate
Article | Year |
---|---|
Intracellular nucleotide levels during coadministration of tenofovir disoproxil fumarate and didanosine in HIV-1-infected patients.
Topics: Adenine; Adult; Aged; Anti-HIV Agents; Chromatography, Liquid; Deoxyadenine Nucleotides; Deoxyguanine Nucleotides; Didanosine; Dideoxynucleotides; Female; HIV Infections; Humans; Male; Middle Aged; Nucleotides; Organophosphonates; Tandem Mass Spectrometry; Tenofovir; Young Adult | 2011 |
VS411 reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for antiviral-hyperactivation limiting therapeutics.
Topics: Adult; Analysis of Variance; Anti-HIV Agents; Biomarkers; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Delayed-Action Preparations; Deoxyadenine Nucleotides; Didanosine; Dideoxynucleotides; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; HIV Infections; HIV-1; Humans; Immunomodulation; Male; Placebos; RNA, Viral; Urea; Viral Load | 2012 |
4 other study(ies) available for 2',3'-dideoxyadenosine triphosphate and 2'-deoxyadenosine triphosphate
Article | Year |
---|---|
Inhibition of human immunodeficiency virus reverse transcriptase by synadenol triphosphate and its E-isomer.
Topics: Anti-HIV Agents; HIV Reverse Transcriptase; Mutation; Nucleosides; Reverse Transcriptase Inhibitors; Stereoisomerism | 2003 |
Anti-human immunodeficiency virus activity, cross-resistance, cytotoxicity, and intracellular pharmacology of the 3'-azido-2',3'-dideoxypurine nucleosides.
Topics: Anti-HIV Agents; Cell Line, Tumor; Cell Survival; Cells, Cultured; Dideoxynucleosides; HIV Infections; HIV-1; Humans; Molecular Structure; Reverse Transcriptase Inhibitors | 2009 |
Selective inhibition of HIV-1 reverse transcriptase by an antiviral inhibitor, (R)-9-(2-Phosphonylmethoxypropyl)adenine.
Topics: Adenine; Animals; Anti-HIV Agents; Deoxyadenine Nucleotides; Dideoxynucleotides; DNA Polymerase beta; HIV Reverse Transcriptase; Kinetics; Models, Chemical; Organophosphonates; Organophosphorus Compounds; Rats; Reverse Transcriptase Inhibitors; RNA, Viral; Tenofovir | 1998 |
Identification of a domain conferring nucleotide binding to the N-acetyl-d-glucosamine 2-epimerase (Renin binding protein).
Topics: Adenosine Triphosphate; Animals; Blotting, Western; Carbohydrate Epimerases; Carrier Proteins; Catalytic Domain; Deoxyadenine Nucleotides; Dideoxynucleotides; DNA, Complementary; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Humans; Models, Molecular; Nucleotides; Plasmids; Protein Structure, Tertiary; Rats; Renin; Thermolysin | 2002 |